Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- TamaBio to Showcase Synthetic Biomembrane Technology at ACS Clinical Congress 2026 in Washington, D.C.TamaBio to Showcase Synthetic Biomembrane Technology at ACS Clinical Congress 2026 in Washington, D.C.
- The Rosen Law Firm PAROSEN, TRUSTED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead plaintiff deadline.SO WHAT: If you purchased Hims securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a...
- Edelson Lechtzin LLPMEDIMPACT DATA BREACH: Edelson Lechtzin LLP Launches Investigation Into Exposure of Social Security Numbers and Health InformationNational class action firm Edelson Lechtzin LLP is offering free case evaluations to individuals affected by the MedImpact Healthcare Systems data breach, which may have exposed names, Social Security numbers, and sensitive health information. SAN DIEGO, Sept. 26, 2026 --...
- Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein ImmediatelyLead Plaintiff Deadline November 2, 2026
- Halper Sadeh LLPDid Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders should contact the...
- Halper Sadeh LLPDid CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders should contact the...
- Kahn Swick & Foti, LLCHims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until November 2, 2026 to file lead plaintiff applications in a securities...
- The Rosen Law Firm PAROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead plaintiff deadline.SO WHAT: If you purchased Hims securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a...
- Robbins Geller Rudman & Dowd LLP1 WEEK PNR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Pentair plc and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit Before October 2, 2026 DeadlineRobbins Geller Rudman & Dowd LLP announces that purchasers of Pentair plc (NYSE: PNR) ordinary shares between March 11, 2025 and July 14, 2026, inclusive (the "Class Period"), have until Friday, October 2, 2026 to seek appointment as lead plaintiff of the Pentair class action lawsuit. Captioned City of Warren General Retirement Health, Life and Disability Benefits Plan and Trust v. Pentair plc, No. 26-cv-03597 (D. Minn.), the...
- ROSEN, SKILLED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the “Class Period”), of the important November 2, 2026 lead plaintiff deadline.
- Cutting-Edge Liver Surgery in India: Premium Quality, Budget- Friendly CostsAccess advanced liver cancer care with experienced specialists, modern hospitals, and cost-effective treatment options. Patients can receive personalized treatment guidance and complete support throughout their medical journey.
- Curaechoice BirminghamChrysalis Health and Curaechoice Join Forces to Address Cost and Access Barriers to Mental Health CareStrategic collaboration expands no-cost access to trusted in-person and virtual mental health services, helping employers simplify care while improving affordability and access for employees and their families.